[go: up one dir, main page]

DE69713094D1 - Verfahren zur erkennung von malignen transformierten menschlichen zellen - Google Patents

Verfahren zur erkennung von malignen transformierten menschlichen zellen

Info

Publication number
DE69713094D1
DE69713094D1 DE69713094T DE69713094T DE69713094D1 DE 69713094 D1 DE69713094 D1 DE 69713094D1 DE 69713094 T DE69713094 T DE 69713094T DE 69713094 T DE69713094 T DE 69713094T DE 69713094 D1 DE69713094 D1 DE 69713094D1
Authority
DE
Germany
Prior art keywords
hcg
detecting
maligning
human cells
transformed human
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69713094T
Other languages
English (en)
Other versions
DE69713094T2 (de
Inventor
Dominique Bellet
Jean-Michel Bidart
Michel Vidaud
Vladimir Lazar
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Institut Gustave Roussy (IGR)
Original Assignee
Institut Gustave Roussy (IGR)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Institut Gustave Roussy (IGR) filed Critical Institut Gustave Roussy (IGR)
Application granted granted Critical
Publication of DE69713094D1 publication Critical patent/DE69713094D1/de
Publication of DE69713094T2 publication Critical patent/DE69713094T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/156Polymorphic or mutational markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Hospice & Palliative Care (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Oncology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
DE69713094T 1996-03-04 1997-02-28 Verfahren zur erkennung von malignen transformierten menschlichen zellen Expired - Fee Related DE69713094T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9602683A FR2745638A1 (fr) 1996-03-04 1996-03-04 Procede pour la detection de la transformation maligne de cellules humaines
PCT/FR1997/000361 WO1997032997A2 (fr) 1996-03-04 1997-02-28 Procede pour la detection de la transformation maligne de cellules humaines

Publications (2)

Publication Number Publication Date
DE69713094D1 true DE69713094D1 (de) 2002-07-11
DE69713094T2 DE69713094T2 (de) 2003-01-16

Family

ID=9489816

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69713094T Expired - Fee Related DE69713094T2 (de) 1996-03-04 1997-02-28 Verfahren zur erkennung von malignen transformierten menschlichen zellen

Country Status (8)

Country Link
US (2) US6194154B1 (de)
EP (1) EP0902840B1 (de)
JP (1) JP2000513210A (de)
AT (1) ATE218620T1 (de)
CA (1) CA2248264A1 (de)
DE (1) DE69713094T2 (de)
FR (1) FR2745638A1 (de)
WO (1) WO1997032997A2 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003012445A1 (en) 2001-07-30 2003-02-13 Quest Diagnostics Investments Incorporated Methods and kits for detecting ita in a biological sample
DE10361928A1 (de) * 2002-12-21 2004-07-01 Universität Leipzig Verfahren und Mittel zur Bestimmung von bestimmten Zuständen bzw. Veränderungen im Uterusepithel und im Epithel anderer Organe
EP1583846B1 (de) * 2003-01-17 2011-11-16 The Chinese University Of Hong Kong Zirkulierende mrna als diagnostische marker für erkankungen die mit einer schwangerschaft zusammenhängen
ATE521896T1 (de) * 2003-06-06 2011-09-15 Biotype Diagnostic Gmbh Verfahren und mittel zur bestimmung von definierten zuständen oder veränderungen in der uterusschleimhaut oder im epithel anderer organe
GB201308259D0 (en) 2013-05-08 2013-06-12 Iles Raymond K Cancer diagnosis and monitoring

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ262435A (en) * 1993-03-11 1997-05-26 Lafon Labor Kit for diagnosing an hcg fragment secreting cancer and immunotherapeutical means therefor

Also Published As

Publication number Publication date
US6194154B1 (en) 2001-02-27
JP2000513210A (ja) 2000-10-10
EP0902840B1 (de) 2002-06-05
WO1997032997A2 (fr) 1997-09-12
DE69713094T2 (de) 2003-01-16
CA2248264A1 (fr) 1997-09-12
US20020192646A1 (en) 2002-12-19
EP0902840A2 (de) 1999-03-24
FR2745638A1 (fr) 1997-09-05
ATE218620T1 (de) 2002-06-15
WO1997032997A3 (fr) 1997-10-30
US6514708B2 (en) 2003-02-04

Similar Documents

Publication Publication Date Title
DK0917571T3 (da) Hidtil ukendt agoutirelateret gen
WO2004037999A3 (en) A34 and a33-like 3 dna, proteins, antibodies thereto and methods of treatment using same
NO963371L (no) Hematopoietisk protein samt materialer og fremgangsmåter for fremstilling av det
TW200728465A (en) Compositions and methods for the therapy and diagnosis of prostate cancer
TW428026B (en) Bifunctional protein, preparation and use
IL140550A (en) Methods for early diagnosis of carcinomas
PL350318A1 (en) Protein isolation and analysis
WO2003060090A3 (en) Novel cytokine zcytor17 ligand
DK0858467T3 (da) Materialer og fremgangsmåder angående identifikationen og sekventeringen af BRCA2 cancerfölsomhedsgen og anvendelser deraf
DE3856301D1 (de) Dns sequenzen, rekombinante dns-moleküle sowie verfahren zur herstellung des an der lymphocyten-funktion assoziierten antigens-3
DE69717664D1 (de) Protein e25a, methoden zu dessen herstellung und anwendung
DE69932153D1 (en) Phosphodiesterase 10
DE69713094D1 (de) Verfahren zur erkennung von malignen transformierten menschlichen zellen
ATE275626T1 (de) Verfahren zur herstellung von rekombinanten menschlichen lh-rh rezeptor proteinen in spezifischen cho zellinien.
IL130164A0 (en) Mammalian chemokines
EP0833948A4 (de) Für den dickdarm spezifische gene und proteine
DK0495910T3 (da) Fremstilling og anvendelse af humant nm23-H2-protein og derimod rettede antistoffer
WO1998045442A3 (en) Secreted f-spondin homologs
ATE305140T1 (de) Verfahren zur detektion der hk2 polypeptide
DE69735676D1 (de) Proteinmarker für ösophaguskrebs
YU5002A (sh) Jedinjenja i postupci za lečenje i dijagnozu raka pluća
ATE214160T1 (de) Überwachung der immunotherapie von malignen tumoren
WO2002034917A3 (en) Secreted alpha-helical cytokine-like protein zlmda24
ATE234356T1 (de) Menschliches zelladhäsionsmolekülaamp-1 und dessen verwendungen
EP1496065A3 (de) Brustspezifische Gene und Proteine

Legal Events

Date Code Title Description
8339 Ceased/non-payment of the annual fee